FDA 510(k) · Withings

K201456: Scan Monitor (Withings SA)

Withings SA received FDA 510(k) K201456 for Scan Monitor, with a decision date of Oct 5, 2021 (substantially equivalent).

Prescription or OTC: Unknown (no FDA document we parsed states it).

FDA record for K201456FDA summary or statement (PDF)

FDA facts

Official fields for K201456
FDA numberK201456
Pathway510(k)
ApplicantWithings SA
Device nameScan Monitor
Product codeDPS: Electrocardiograph
Regulation (21 CFR)870.2340
Device classClass 2
Date receivedJun 1, 2020
Decision dateOct 5, 2021
DecisionSubstantially Equivalent (SESE)
510(k) typeTraditional

Source: openFDA device 510(k) data, data through Oct 26, 2026.

Indications for use parsed from FDA documents

Scan Monitor is intended to record, store and transfer single-channel electrocardiogram (ECG) rhythms. The Scan Monitor also displays ECG rhythms and detects the presence of atrial fibrillation (when the monitor is prescribed or used under the care of a physician). The Scan Monitor is intended for use by healthcare professionals, patients with known or suspected heart conditions and health-conscious individuals. The Scan Monitor is also indicated for use in measuring and displaying functional oxygen saturation of arterial hemoglobin (%SpO2). The Scan Monitor is intended for spot-checking of adult patients in hospitals, clinics, long-term care facilities, and homes.

Extracted automatically from FDA's 510(k) summary. It can contain extraction errors and is not a verified quote. Read the wording in the FDA PDF before relying on it.

Predicates parsed from FDA documents

FDA numbers found next to the word "predicate" in the summary. The list can include reference devices; check the PDF for which device is the primary predicate.

Later records that cite K201456

  • K243305 Masimo W1 (Masimo, Apr 3, 2025, DPS)
  • K232512 Masimo W1 (Masimo, Nov 17, 2023, DPS)
  • K230812 Withings Scan Monitor 2.0 (Withings, Aug 23, 2023, DPS)
  • K221260 CSF-3 (Cardiac Sense, Jan 6, 2023, DPS)

ChatPPG interpretation

A 510(k) decision of "substantially equivalent" means FDA found the device as safe and effective as a legally marketed predicate. FDA's word for this is cleared, not approved. The clearance covers the device and indications in this submission; it does not extend to other features or versions of the same product that were not part of it. See FDA cleared vs approved.

Product code DPS is "Electrocardiograph", class 2, 21 CFR 870.2340.

Our labels for filtering: claim ECG, sensor ECG electrodes. These are heuristics, not FDA fields.